Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Scandinavian Journal of Immunology
|
April 5, 2021
Pituitary neuropeptides and B lymphocyte function
Ann L Benko, A Dale Wright, Teresa Sunyer, et al.
Journal of Neuroimmunology
|
February 18, 2021
Individual pituitary neuropeptides do not recapitulate the effects of repository corticotropin (Acthar®) on human B cells in vitro
Ann L Benko, A Dale Wright, Teresa Sunyer, et al.
Arthritis and Rheumatism
|
June 10, 2010
Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: confirmation by multivariate analysis that modulation of type II collagen and aggrecan degradation peptides parallels pathologic changes
Steven Settle, Lillian Vickery, Olga Nemirovskiy, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
June 1, 2010
Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis
Olga Nemirovskiy, Yi J Zheng, David Tung, et al.
Nitric Oxide : Biology and Chemistry
|
January 17, 2009
Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: Pharmacological dissection of iNOS' role in disease
Olga V Nemirovskiy, Melissa R Radabaugh, Poonam Aggarwal, et al.
Annals of the Rheumatic Diseases
|
June 6, 2009
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
Astrid Jüngel, Caroline Ospelt, Mark Lesch, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
Peter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Journal of Medicinal Chemistry
|
August 24, 2010
Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease
Daniel P Becker, Thomas E Barta, Louis J Bedell, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
Mark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Scandinavian Journal of Immunology
|
April 5, 2021
Pituitary neuropeptides and B lymphocyte function
Ann L Benko, A Dale Wright, Teresa Sunyer, et al.
Journal of Neuroimmunology
|
February 18, 2021
Individual pituitary neuropeptides do not recapitulate the effects of repository corticotropin (Acthar®) on human B cells in vitro
Ann L Benko, A Dale Wright, Teresa Sunyer, et al.
Arthritis and Rheumatism
|
June 10, 2010
Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: confirmation by multivariate analysis that modulation of type II collagen and aggrecan degradation peptides parallels pathologic changes
Steven Settle, Lillian Vickery, Olga Nemirovskiy, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
June 1, 2010
Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis
Olga Nemirovskiy, Yi J Zheng, David Tung, et al.
Nitric Oxide : Biology and Chemistry
|
January 17, 2009
Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: Pharmacological dissection of iNOS' role in disease
Olga V Nemirovskiy, Melissa R Radabaugh, Poonam Aggarwal, et al.
Annals of the Rheumatic Diseases
|
June 6, 2009
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
Astrid Jüngel, Caroline Ospelt, Mark Lesch, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
Peter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Journal of Medicinal Chemistry
|
August 24, 2010
Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease
Daniel P Becker, Thomas E Barta, Louis J Bedell, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
Mark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Page
of 1